Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Akebia Therapeutics

    Client Virtual Booth

    AKEBIA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Akebia Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, Suite 1400 Cambridge, MA 02142
    Telephone
    Telephone
    +1 617-871-2098
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://akebia.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/akebia-therapeutics/
    Twitter
    Twitter
    https://twitter.com/akebiatx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302106295.html

    PR NEWSWIRE
    02 Apr 2024
    Share Share
    U.S. FDA approves Akebia's anemia drug
    U.S. FDA approves Akebia's anemia drug

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-akebias-anemia-drug-2024-03-28/

    REUTERS
    28 Mar 2024
    Share Share
    Vafseo® Approved by The U.S. Fda for The Treatment of Anemia
    Vafseo® Approved by The U.S. Fda for The Treatment of Anemia

    https://www.prnewswire.com/news-releases/vafseo-approved-by-the-us-fda-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients-302102216.html

    PR NEWSWIRE
    28 Mar 2024
    Share Share
    Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets
    Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets

    https://www.prnewswire.com/news-releases/akebia-receives-fda-approval-of-vafseo-vadadustat-tablets-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-adult-patients-on-dialysis-302101854.html

    PR NEWSWIRE
    27 Mar 2024
    Share Share
    Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results-and-recent-business-highlights-302089807.html

    PR NEWSWIRE
    14 Mar 2024
    Share Share
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302077525.html

    PR NEWSWIRE
    01 Mar 2024
    Share Share
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302052311.html

    PR NEWSWIRE
    02 Feb 2024
    Share Share
    Akebia Announces Appointment of Nicholas Grund as Chief Commercial Officer
    Akebia Announces Appointment of Nicholas Grund as Chief Commercial Officer

    https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-appointment-of-nicholas-grund-as-chief-commercial-officer-302029322.html

    PR NEWSWIRE
    09 Jan 2024
    Share Share
    Akebia to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    Akebia to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019671.html

    PR NEWSWIRE
    20 Dec 2023
    Share Share
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Akebia Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302003603.html

    PR NEWSWIRE
    01 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search